---
$id: https://graph.org.ai/products/commodity/51191923
$type: Product
source: UNSPSC
code: "51191923"
title: "Tretinoin"
class: "51191900"
classTitle: "Nutritional therapy products"
family: "51190000"
familyTitle: "Agents affecting water and electrolytes"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tretinoin

**UNSPSC Code**: 51191923
**Class**: [Nutritional therapy products](Nutritional therapy products.mdx)
**Family**: [Agents affecting water and electrolytes](../Agents affecting water and electrolytes.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a retinoic acid agent with the molecular formula C20H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5688UTC01R, chemically known as 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8-tetraenoic acid but generally known as retinoic acid, which bears US NIH Compound Identifier 5538. European Medicines Agency schedules Retinoic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20680. The term TRETINOIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules retinoic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule tretinoin under HS 29362100 and SITC 54112. As of Q4 2014, TRETINOIN remains the US FDA Preferred Term for this commodity. Tretinoin bears US NLM identifiers UMLS ID C0040845 and NCI Concept Code C900. SMILES: OC(=O)/C=C(/C=C/C=C(/C=C/C1=C(CCCC1(C)C)C)C)C.

